Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterocolitis, Necrotizing | 12 | 2026 | 255 | 3.230 |
Why?
|
| Parenteral Nutrition | 14 | 2026 | 216 | 3.040 |
Why?
|
| Fat Emulsions, Intravenous | 11 | 2025 | 80 | 2.760 |
Why?
|
| Short Bowel Syndrome | 4 | 2022 | 63 | 2.690 |
Why?
|
| Fish Oils | 10 | 2026 | 82 | 1.860 |
Why?
|
| Cholestasis | 7 | 2025 | 165 | 1.800 |
Why?
|
| Liver Diseases | 5 | 2026 | 385 | 1.780 |
Why?
|
| Intestinal Diseases | 4 | 2022 | 69 | 1.590 |
Why?
|
| Infant, Premature | 9 | 2024 | 859 | 1.480 |
Why?
|
| Ostomy | 2 | 2023 | 11 | 1.460 |
Why?
|
| Intestines | 6 | 2026 | 592 | 1.320 |
Why?
|
| Infant, Newborn | 30 | 2026 | 8613 | 1.250 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2023 | 181 | 1.170 |
Why?
|
| Intensive Care Units, Neonatal | 5 | 2026 | 342 | 1.080 |
Why?
|
| Dietary Supplements | 3 | 2026 | 454 | 1.010 |
Why?
|
| Soybean Oil | 8 | 2024 | 71 | 0.920 |
Why?
|
| Infant | 22 | 2026 | 13355 | 0.840 |
Why?
|
| Infant Formula | 3 | 2020 | 104 | 0.830 |
Why?
|
| Lipids | 2 | 2026 | 566 | 0.810 |
Why?
|
| Neonatologists | 2 | 2026 | 23 | 0.770 |
Why?
|
| Infant, Premature, Diseases | 4 | 2024 | 255 | 0.670 |
Why?
|
| Milk, Human | 3 | 2020 | 318 | 0.660 |
Why?
|
| Probiotics | 1 | 2023 | 227 | 0.660 |
Why?
|
| Central Venous Catheters | 1 | 2021 | 51 | 0.650 |
Why?
|
| Health Services Accessibility | 1 | 2026 | 702 | 0.620 |
Why?
|
| Catheterization, Central Venous | 1 | 2021 | 142 | 0.610 |
Why?
|
| Fetal Diseases | 1 | 2023 | 461 | 0.590 |
Why?
|
| Parenteral Nutrition, Total | 2 | 2020 | 114 | 0.560 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2019 | 172 | 0.560 |
Why?
|
| Argininosuccinate Lyase | 4 | 2018 | 62 | 0.550 |
Why?
|
| Enterocytes | 2 | 2018 | 68 | 0.550 |
Why?
|
| Thrombosis | 1 | 2021 | 497 | 0.480 |
Why?
|
| Length of Stay | 3 | 2026 | 1403 | 0.450 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2014 | 8 | 0.440 |
Why?
|
| Mouth Abnormalities | 1 | 2014 | 15 | 0.440 |
Why?
|
| Syndactyly | 1 | 2014 | 23 | 0.440 |
Why?
|
| Apnea | 1 | 2014 | 28 | 0.430 |
Why?
|
| Maxilla | 1 | 2014 | 42 | 0.430 |
Why?
|
| Humans | 43 | 2026 | 132158 | 0.430 |
Why?
|
| Fingers | 1 | 2014 | 63 | 0.430 |
Why?
|
| Eye Abnormalities | 1 | 2014 | 107 | 0.410 |
Why?
|
| Mandible | 1 | 2014 | 98 | 0.410 |
Why?
|
| Knee Joint | 1 | 2014 | 173 | 0.400 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2014 | 58 | 0.400 |
Why?
|
| Ileum | 2 | 2025 | 124 | 0.390 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 161 | 0.380 |
Why?
|
| Nitric Oxide | 4 | 2018 | 469 | 0.370 |
Why?
|
| Intestinal Perforation | 2 | 2024 | 50 | 0.370 |
Why?
|
| Cleft Lip | 1 | 2014 | 190 | 0.350 |
Why?
|
| Infant, Extremely Low Birth Weight | 3 | 2024 | 41 | 0.350 |
Why?
|
| Cleft Palate | 1 | 2014 | 219 | 0.350 |
Why?
|
| Enteral Nutrition | 2 | 2023 | 281 | 0.320 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2026 | 1252 | 0.310 |
Why?
|
| Food, Fortified | 2 | 2020 | 64 | 0.300 |
Why?
|
| Triglycerides | 4 | 2022 | 605 | 0.290 |
Why?
|
| Scrotum | 1 | 2009 | 30 | 0.290 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 977 | 0.290 |
Why?
|
| Argininosuccinic Aciduria | 3 | 2014 | 53 | 0.280 |
Why?
|
| Tuberculosis, Miliary | 1 | 2007 | 10 | 0.270 |
Why?
|
| Testis | 1 | 2009 | 413 | 0.250 |
Why?
|
| Cohort Studies | 4 | 2025 | 5124 | 0.250 |
Why?
|
| Intestinal Atresia | 1 | 2025 | 21 | 0.240 |
Why?
|
| Fatty Acids, Essential | 1 | 2025 | 6 | 0.230 |
Why?
|
| Neonatology | 1 | 2026 | 62 | 0.230 |
Why?
|
| Docosahexaenoic Acids | 3 | 2025 | 67 | 0.230 |
Why?
|
| Bias | 1 | 2026 | 145 | 0.230 |
Why?
|
| Olive Oil | 2 | 2022 | 24 | 0.230 |
Why?
|
| Gestational Age | 3 | 2024 | 1237 | 0.230 |
Why?
|
| Jejunum | 1 | 2025 | 124 | 0.220 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2007 | 259 | 0.220 |
Why?
|
| Birth Weight | 2 | 2023 | 347 | 0.220 |
Why?
|
| Surveys and Questionnaires | 2 | 2026 | 4078 | 0.210 |
Why?
|
| United States | 3 | 2026 | 11867 | 0.210 |
Why?
|
| Laparotomy | 1 | 2024 | 144 | 0.200 |
Why?
|
| Ileus | 1 | 2023 | 11 | 0.190 |
Why?
|
| Drainage | 1 | 2024 | 252 | 0.190 |
Why?
|
| Retrospective Studies | 10 | 2025 | 17763 | 0.190 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2007 | 500 | 0.190 |
Why?
|
| Arginine | 4 | 2018 | 336 | 0.180 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 767 | 0.180 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 545 | 0.180 |
Why?
|
| Feeding Behavior | 1 | 2007 | 724 | 0.180 |
Why?
|
| Bilirubin | 1 | 2022 | 127 | 0.180 |
Why?
|
| Male | 18 | 2025 | 65464 | 0.170 |
Why?
|
| Ultrasonography | 1 | 2026 | 979 | 0.170 |
Why?
|
| Fatty Acids | 2 | 2020 | 379 | 0.170 |
Why?
|
| Energy Intake | 2 | 2020 | 502 | 0.160 |
Why?
|
| Female | 16 | 2025 | 71430 | 0.160 |
Why?
|
| Swine | 6 | 2020 | 1188 | 0.160 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 150 | 0.160 |
Why?
|
| Micronutrients | 1 | 2020 | 61 | 0.150 |
Why?
|
| Growth | 1 | 2020 | 92 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 170 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 333 | 0.150 |
Why?
|
| Milk | 1 | 2019 | 109 | 0.150 |
Why?
|
| Premature Birth | 2 | 2020 | 426 | 0.150 |
Why?
|
| Swine Diseases | 2 | 2020 | 40 | 0.140 |
Why?
|
| Cattle | 1 | 2019 | 503 | 0.140 |
Why?
|
| Emulsions | 2 | 2019 | 70 | 0.140 |
Why?
|
| Sepsis | 2 | 2019 | 496 | 0.140 |
Why?
|
| Metabolome | 1 | 2020 | 328 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 259 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2024 | 13017 | 0.130 |
Why?
|
| Fetal Development | 1 | 2018 | 130 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 776 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 372 | 0.130 |
Why?
|
| Citrulline | 1 | 2018 | 123 | 0.130 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2008 | 63 | 0.120 |
Why?
|
| Animals | 11 | 2020 | 34288 | 0.120 |
Why?
|
| Critical Illness | 1 | 2021 | 616 | 0.120 |
Why?
|
| Colitis | 1 | 2018 | 163 | 0.120 |
Why?
|
| Smad7 Protein | 1 | 2016 | 5 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 4692 | 0.120 |
Why?
|
| Hospitals, Pediatric | 2 | 2025 | 801 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 265 | 0.110 |
Why?
|
| Microbiota | 1 | 2020 | 449 | 0.110 |
Why?
|
| Pregnancy | 4 | 2023 | 7603 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3858 | 0.110 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 65 | 0.100 |
Why?
|
| Compassionate Use Trials | 1 | 2014 | 17 | 0.100 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 99 | 0.100 |
Why?
|
| Phospholipids | 1 | 2014 | 103 | 0.100 |
Why?
|
| Inflammation | 2 | 2018 | 1503 | 0.100 |
Why?
|
| Child | 7 | 2024 | 26383 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 463 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 229 | 0.100 |
Why?
|
| Infant, Extremely Premature | 1 | 2014 | 112 | 0.100 |
Why?
|
| Hyperbilirubinemia | 1 | 2012 | 41 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2014 | 187 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 495 | 0.090 |
Why?
|
| Transfection | 1 | 2014 | 960 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2018 | 3864 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2014 | 418 | 0.090 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 2002 | 2 | 0.090 |
Why?
|
| Cell Line | 2 | 2014 | 2591 | 0.090 |
Why?
|
| Macrophages | 1 | 2016 | 664 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2025 | 1406 | 0.090 |
Why?
|
| Cyclosporine | 1 | 2002 | 131 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1020 | 0.080 |
Why?
|
| Risk | 1 | 2012 | 739 | 0.080 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2017 | 214 | 0.080 |
Why?
|
| Cell Movement | 1 | 2014 | 882 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2002 | 313 | 0.080 |
Why?
|
| Texas | 2 | 2020 | 3657 | 0.080 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 1999 | 7 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 653 | 0.080 |
Why?
|
| Fanconi Anemia | 1 | 1999 | 48 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 121 | 0.070 |
Why?
|
| High-Frequency Ventilation | 1 | 2008 | 19 | 0.070 |
Why?
|
| Rats | 1 | 2014 | 3459 | 0.070 |
Why?
|
| Minisatellite Repeats | 1 | 2007 | 45 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 664 | 0.070 |
Why?
|
| Apoptosis | 1 | 2014 | 1863 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2012 | 725 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 6544 | 0.060 |
Why?
|
| alpha-Linolenic Acid | 1 | 2025 | 15 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2025 | 22 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 3096 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2025 | 54 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2009 | 323 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 395 | 0.060 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2006 | 170 | 0.050 |
Why?
|
| Spontaneous Perforation | 1 | 2024 | 4 | 0.050 |
Why?
|
| Mice | 4 | 2016 | 18397 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2025 | 82 | 0.050 |
Why?
|
| Time Factors | 1 | 2014 | 6288 | 0.050 |
Why?
|
| Linear Models | 1 | 2025 | 696 | 0.050 |
Why?
|
| Liver Transplantation | 2 | 2024 | 1133 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1916 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2020 | 3458 | 0.050 |
Why?
|
| Risk Factors | 3 | 2025 | 11034 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3939 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2006 | 404 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 4734 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2024 | 1081 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2024 | 401 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1526 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2025 | 1230 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 79 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2024 | 15103 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1074 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 3439 | 0.040 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 22 | 0.030 |
Why?
|
| Phytosterols | 1 | 2017 | 28 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 550 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 169 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2016 | 46 | 0.030 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 57 | 0.030 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 142 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 303 | 0.030 |
Why?
|
| Child Development | 1 | 2017 | 277 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2018 | 902 | 0.030 |
Why?
|
| Diet | 1 | 2020 | 1119 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 451 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 3357 | 0.020 |
Why?
|
| Argininosuccinate Synthase | 1 | 2011 | 25 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 48 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 168 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 330 | 0.020 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 627 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2002 | 288 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 381 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2567 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2002 | 291 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 665 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 1999 | 364 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 530 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 869 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2002 | 1240 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3253 | 0.020 |
Why?
|
| Adult | 1 | 2007 | 31755 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1746 | 0.010 |
Why?
|
| Liver | 1 | 2012 | 1805 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 1364 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 4699 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 21018 | 0.010 |
Why?
|